Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Masszi, Tamás

Class:IdPerson:9685422
_displayNameMasszi, Tamás
_timestamp2020-04-23 13:12:19
created[InstanceEdit:9685409] Jassal, Bijay, 2020-04-23
firstnameTamás
initialT
surnameMasszi
(author)[LiteratureReference:9685427] Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study
[LiteratureReference:9758778] Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection
[LiteratureReference:9957082] Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups
[Change default viewing format]
No pathways have been reviewed or authored by Masszi, Tamás (9685422)